The US Food and Drug Administration has upgraded a recall of cough drops to Class II, indicating that consumption may lead to adverse health consequences. The recall, initially announced on 20 March, was raised to the higher classification on 10 April.
The cough drops were manufactured by Xiamen Kang Zhongyuan Biotechnology Co., Ltd., a company based in China. The recall was prompted by an FDA inspection of the manufacturing facility in August 2025, though further details about the specific issues have not been disclosed.
Multiple brands and products are affected by the recall. Consumers can find a full list of lot codes and expiration dates on the FDA’s website. No formal press release has been issued for this recall.
It is recommended that consumers discard any recalled cough drops or return them to the place of purchase for a refund. This recall is the latest in a series of product withdrawals during allergy season.
